Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial

IMPORTANCE: Therapeutic options are needed for patients with advanced gastric cancer whose disease has progressed after 2 or more lines of therapy. OBJECTIVE: To evaluate the safety and efficacy of pembrolizumab in a cohort of patients with previously treated gastric or gastroesophageal junction can...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:JAMA Oncol
Main Authors: Fuchs, Charles S., Doi, Toshihiko, Jang, Raymond W., Muro, Kei, Satoh, Taroh, Machado, Manuela, Sun, Weijing, Jalal, Shadia I., Shah, Manish A., Metges, Jean-Phillipe, Garrido, Marcelo, Golan, Talia, Mandala, Mario, Wainberg, Zev A., Catenacci, Daniel V., Ohtsu, Atsushi, Shitara, Kohei, Geva, Ravit, Bleeker, Jonathan, Ko, Andrew H., Ku, Geoffrey, Philip, Philip, Enzinger, Peter C., Bang, Yung-Jue, Levitan, Diane, Wang, Jiangdian, Rosales, Minori, Dalal, Rita P., Yoon, Harry H.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Medical Association 2018
נושאים:
Original Investigation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885175/
https://ncbi.nlm.nih.gov/pubmed/29543932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.0013
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים